Stock Taper 
STEMPOINT CAPITAL LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Definium Therapeutics, Inc. | DFTX | 137.12K | $6.45M |
 ACADIA Pharmaceuticals Inc. | ACAD | 143.17K | $3.62M |
 Monte Rosa Therapeutics, Inc. | GLUE | 153.54K | $3.72M |
 CG Oncology Inc. | CGON | 159.35K | $11.32M |
 Revolution Medicines, Inc. | RVMD | 159.94K | $29.95M |
 Celldex Therapeutics, Inc. | CLDX | 178.41K | $6.64M |
 Dianthus Therapeutics, Inc. | DNTH | 200.85K | $19.58M |
 Kiniksa Pharmaceuticals International, plc | KNSA | 209.23K | $13.38M |
 Scholar Rock Holding Corporation | SRRK | 239.15K | $13.15M |
 Alkermes plc | ALKS | 248.01K | $12.99M |
 Immunovant, Inc. | IMVT | 276.53K | $10.65M |
 Abivax S.A. | ABVX | 283.66K | $37.8M |
 COMPASS Pathways plc | CMPS | 284.77K | $4.03M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 338.47K | $4.84M |
 Enliven Therapeutics, Inc. | ELVN | 346.91K | $17.61M |
 Roivant Sciences Ltd. | ROIV | 348.41K | $12.33M |
 Solid Biosciences Inc. | SLDB | 358.78K | $3.58M |
 Amylyx Pharmaceuticals, Inc. | AMLX | 384.3K | $6.9M |
 BioAge Labs Inc. | BIOA | 464.17K | $11.38M |
 C4 Therapeutics, Inc. | CCCC | 523.65K | $2.45M |